Clinical Trials Browser

Enrolling by invitation × enzalutamide × 90 days × Clear all

NCT04145375 2026-05-08

Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

Phase 1/2 Enrolling by invitation

Prostatic Neoplasms